Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow mononuclear cell injection for idiopathic lymphedema
IRCT20191019045155N4Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone marrow mononuclear cells in Primary lymphedema, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Volume of lower extremities. Started Apr 2014; status: completed.
02
Drugs
bone marrow mononuclear cells
03
Conditions
Primary lymphedema
Beyond the preview
Go deeper on IRCT20191019045155N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191019045155N4.